PS01.56: IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1-Selected Chemotherapy-Naive NSCLC Patients: Topic: Medical Oncology. (Q53632241)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PS01.56: IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1-Selected Chemotherapy-Naive NSCLC Patients: Topic: Medical Oncology. |
scientific article |
Statements
PS01.56: IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1-Selected Chemotherapy-Naive NSCLC Patients: Topic: Medical Oncology. (English)
1 reference
Jacek Jassem
1 reference
Roy S Herbst
1 reference
Simonetta Mocci
1 reference
Filippo De Marinis
1 reference
Sivuonthanh Lam
1 reference
Alan Sandler
1 reference
Ariel Lopez-Chavez
1 reference
Yu Deng
1 reference
Giuseppe Giaccone
1 reference
David R Spigel
1 reference
28 October 2016
1 reference
11
1 reference
11S
1 reference
S304-S305
1 reference